Literature DB >> 22227979

Inclusion of 30-day postdischarge detection triples the incidence of hospital-onset methicillin-resistant Staphylococcus aureus.

Taliser R Avery1, Ken P Kleinman, Michael Klompas, Ann Aschengrau, Susan S Huang.   

Abstract

BACKGROUND: Hospitalized patients are at increased risk for acquisition of methicillin-resistant Staphylococcus aureus (MRSA). As hospital length of stay shortens, hospital-acquired MRSA events may be more likely to be detected after discharge.
OBJECTIVE: We assessed the impact of attributing MRSA cases discovered within 30 days after discharge to the most recent hospitalization and identified patient characteristics associated with MRSA detection after discharge.
DESIGN: Retrospective cohort study.
SETTING: Twenty-seven acute care hospitals in Orange County, California. PARTICIPANTS: Adult acute care admissions (2002-2007).
METHODS: Using a countywide hospital data set containing diagnostic codes with present-on-admission (POA) indicators, we identified the first admission with a MRSA code for each patient. This incident MRSA admission was defined as predischarge-detected (pre-DD) hospital-onset MRSA (HO-MRSA) when MRSA was not POA. If MRSA was POA and a prior admission occurred within 30 days, this prior admission was assigned postdischarge-detected (post-DD) HO-MRSA. We evaluated the impact of including post-DD HO-MRSA in the calculation of hospital HO-MRSA incidence using signed-rank tests and reviewed changes in hospital rankings. We conducted multivariate comparisons of patient characteristics of pre-DD versus post-DD HO-MRSA patients.
RESULTS: Among 1,217,253 at-risk hospitalizations, the inclusion of post-DD HO-MRSA tripled the median hospital HO-MRSA incidence, from 12.2 to 35.7 cases per 10,000 at-risk admissions (P < .0001). Hospital ranking changed substantially when including post-DD HO-MRSA. Patients with shorter stays were more likely to have post-DD MRSA.
CONCLUSIONS: On the basis of administrative claims data, the inclusion of post-DD HO-MRSA significantly increased the estimated HO-MRSA incidence and altered hospital rankings. This finding underscores the limitations of single-facility data when deriving HO-MRSA incidence and rank.

Entities:  

Mesh:

Year:  2011        PMID: 22227979     DOI: 10.1086/663714

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

1.  Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study.

Authors:  Deverick J Anderson; Luke F Chen; David J Weber; Rebekah W Moehring; Sarah S Lewis; Patricia F Triplett; Michael Blocker; Paul Becherer; J Conrad Schwab; Lauren P Knelson; Yuliya Lokhnygina; William A Rutala; Hajime Kanamori; Maria F Gergen; Daniel J Sexton
Journal:  Lancet       Date:  2017-01-17       Impact factor: 79.321

Review 2.  Will there ever be a universal Staphylococcus aureus vaccine?

Authors:  Gerald B Pier
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

3.  The importance of nursing homes in the spread of methicillin-resistant Staphylococcus aureus (MRSA) among hospitals.

Authors:  Bruce Y Lee; Sarah M Bartsch; Kim F Wong; Ashima Singh; Taliser R Avery; Diane S Kim; Shawn T Brown; Courtney R Murphy; Server Levent Yilmaz; Margaret A Potter; Susan S Huang
Journal:  Med Care       Date:  2013-03       Impact factor: 2.983

4.  Postdischarge surveillance to identify subsequent methicillin-resistant Staphylococcus aureus infections in colonized children.

Authors:  Sonali Advani; Arnab Sengupta; Aaron M Milstone
Journal:  Am J Infect Control       Date:  2013-03-07       Impact factor: 2.918

5.  Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.

Authors:  J A Sutcliffe; W O'Brien; C Fyfe; T H Grossman
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

6.  Antiseptic Body Washes for Reducing the Transmission of Methicillin-Resistant Staphylococcus aureus: A Cluster Crossover Study.

Authors:  Patrick N A Harris; Bich Diep Le; Paul Tambyah; Li Yang Hsu; Surinder Pada; Sophia Archuleta; Sharon Salmon; Amartya Mukhopadhyay; Jasmine Dillon; Robert Ware; Dale A Fisher
Journal:  Open Forum Infect Dis       Date:  2015-05-22       Impact factor: 3.835

7.  MRSA nasal carriage patterns and the subsequent risk of conversion between patterns, infection, and death.

Authors:  Kalpana Gupta; Richard A Martinello; Melissa Young; Judith Strymish; Kelly Cho; Elizabeth Lawler
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.